Asia Pacific Diagnostic Electrocardiograph Market
Asia Pacific Diagnostic Electrocardiograph Market by Product & Service (Stress ECG Devices, Holter Monitors, Mobile Cardiac Telemetry), Lead Type (Single-, 3-, 5-, 6-, and 12-lead ECG Device), End User (Hospitals, Ambulatory Surgical Centers) - Forecast to 2032
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The Asia Pacific Diagnostic Electrocardiograph market, valued at USD 1.81 billion in 2025, stood at USD 1.96 billion in 2026 and is projected to advance at a resilient CAGR of 8.9% from 2026 to 2032, culminating in a forecasted valuation of USD 3.27 billion by the end of the period. The high occurrence of cardiovascular diseases (CVDs) in combination with the increasing aging population and the urgent requirement for affordable healthcare are the main factors behind the rise of the diagnostic electrocardiograph market in the Asia Pacific region.
KEY TAKEAWAYS
-
BY PRODUCT & SERVICEBy product & service, the devices segment is expected to register the highest CAGR of 9.1% during the forecast period.
-
BY LEAD TYPEBy lead type, the 12-lead ECG devices segment is expected to dominate the market with a 34.7% share in 2025.
-
BY TYPEBased on type, the market is further classified into portable, wearable, and implantable ECG devices. The portable segment holds the largest share of the diagnostic electrocardiograph market.
-
BY DEPLOYMENT/CONNECTIVITYBy deployment/connectivity, the standalone ECG devices segment held the largest market share of 50.4% in 2025.
-
BY END USERBased on end user, hospitals segment represents the largest share of the diagnostic electrocardiograph market in 2025.
-
BY COUNTRYChina is expected to record the fastest growth rate of 10.7%, driven by a combination of demographic, technological, and healthcare infrastructure developments.
-
COMPETITIVE LANDSCAPE - KEY PLAYERSCompany GE Healthcare, KONINKLIJKE PHILIPS N.V., and Baxter were identified as star players in the Asia Pacific diagnostic electrocardiograph market, given their strong market share and product footprint.
-
COMPETITIVE LANDSACAPE - STARTUPSCompanies such as Eidan Instruments, Inc, Alivecor,Inc among others, have distinguished themselves among startups and SMEs due to their strong product portfolio and business strategy.
The diagnostic electrocardiograph market in Asia Pacific is expected to grow at a considerable rate over the next decade, largely driven by a major shift toward home healthcare solutions and greater advancements in heart diagnosis solutions in Asia Pacific countries. The major use of wearable technology and digitalization in healthcare systems, as seen in China, India, Japan, and Australia, is currently driving a significant increase in demand for diagnostic electrocardiograph systems. In addition, advances in technology, particularly in heart diagnostic solutions that use artificial intelligence, are a key factor currently driving strong growth momentum in the Asia Pacific diagnostic electrocardiograph market.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The Asia Pacific diagnostic electrograph market is undergoing a transformation driven by advancements in digital health, remote patient monitoring, and integration with AI-powered analytics. Traditional hospital-based ECG diagnostics give way to portable, wearable, and home-based solutions, creating new revenue sources and end users. These trends are reshaping clinical workflows and enabling proactive, decentralized cardiac care.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Level
-
Increasing incidence of lifestyle and cardiovascular diseases
-
Rapidly expanding global geriatric population and subsequent surge in heart conditions
Level
-
Regulatory variability and approval complexities across Asia Pacific countries
-
Technological limitations of diagnostic ECG devices and software
Level
-
High-growth opportunities in Emerging Asia Pacific markets
-
Expanding access to advanced cardiac diagnostics with AI and CMS support
Level
-
Challenges in integrating ECG systems with electronic health records
-
Accuracy challenges in next-generation ECG monitoring
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
ASIA PACIFIC DIAGNOSTIC ELECTROCARDIOGRAPH MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
AI-powered portable ECG devices for personalized cardiac care | Uses AI to detect atrial fibrillation, bradycardia, and tachycardia | The device works with smartphones to record medical-grade ECGs, providing instant analysis and alerts |
 |
Wearable ECG monitors integrated with deep learning analytics | Continuously records cardiac activity for up to 14 days | Data is analyzed using AI-driven algorithms to detect arrhythmias and other anomalies with high accuracy | This solution reduces diagnostic delays and hospital visits while supporting physicians with comprehensive cardiac insights in a streamlined digital report |
 |
Portable and wearable ECG devices; AI-powered interpretation | Enables remote monitoring, faster diagnosis, better patient convenience and supports scaling in ambulatory and home settings |
 |
12-lead resting ECG systems; advanced digital ECG | Offers high diagnostic accuracy | broad clinical acceptance | essential for detecting myocardial infarction and arrhythmia |supports large hospital workflows |
 |
Clinical-grade ECG systems for continuous cardiac monitoring and diagnostics | Delivers accurate ECG acquisition and interpretation, enabling continuous monitoring, rapid arrhythmia detection, and reliable diagnosis of acute cardiac events across hospitals in Japan and other Asia Pacific countries |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The Asia Pacific diagnostic electrocardiograph ecosystem comprises various stakeholders such as manufacturers, suppliers, healthcare service providers, regulatory bodies, and end users, who are all involved closely in the design, manufacture, and deployment of ECG systems and their related components. Manufacturers purchase parts from the suppliers and especially need sensors, electrodes, cables, display screens, batteries, medical-grade plastics, conductive gels, and adhesives. Besides that, they also take care of system integration, calibration, and testing in-house. Hospitals, diagnostic labs, clinics, ambulatory care centers, and, generally, healthcare providers are the largest end users of these devices. Hence, the need for accurate, real-time cardiac data for diagnosis and monitoring of heart conditions is among their main driver of demand. Different regulatory authorities across the Asia Pacific region, such as China’s NMPA, Japan’s PMDA, Australia’s TGA, and India’s CDSCO, are ensuring that the devices meet standards related to safety, efficacy, interoperability, and patient data protection, before issuing product approval and post-market surveillance time extensions. People such as cardiologists, physicians, and technicians, and patients who do ECG at home have the greatest influence on market trends through their increasing need for small, portable, easy-to-use ECG devices with such features as wireless connectivity, remote monitoring, and integration with electronic health records (EHRs) capabilities.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Asia Pacific Diagnostic Electrocardiograph Market, By Product & Service
The devices segment accounted for the largest share of the Asia Pacific diagnostic electrocardiograph market IN 2025. This segment refers to various types of products such as resting ECG devices, stress ECG systems, Holter monitors, smart ECG devices, mobile cardiac telemetry (MCT) devices, and implantable loop recorders (ILRs). These diagnostic devices are essential as the CVDs continue to be the most significant cause of global health problems. They are the main means through which early intervention and effective risk assessment are facilitated as they provide timely and accurate diagnostic information and are also instrumental patient monitoring processes. The continuous development and use of such technologies are the main steps towards the improvement of cardiac health and patient outcomes.
Asia Pacific Diagnostic Electrocardiograph Market, By Lead Type
During the forecast period, single-lead ECG devices are expected to register the highest growth rate among all lead types. This growth is driven by their simplicity, portability, and ease of use, making them well suited for ambulatory care, home healthcare, and remote patient monitoring. Compared with multi-lead systems, single-lead ECG devices are less complex, more cost-effective, and more comfortable for patients, enabling frequent and long-term cardiac monitoring. The rising prevalence of cardiovascular diseases, coupled with increasing adoption of wearable and smartphone-connected ECG devices for early detection and continuous monitoring, is further accelerating demand and supporting rapid expansion of the single-lead ECG segment across both developed and emerging markets.
Asia Pacific Diagnostic Electrocardiograph Market, By Type
In 2025, the portable segment dominated the Asia Pacific diagnostic electrocardiograph market due to the convenience, mobility, and broad applicability of portable devices across clinical and home-care settings. Unlike conventional, stationary ECG systems, portable devices enable on-demand or continuous cardiac monitoring from virtually any location. Their ability to wirelessly capture and transmit ECG data to healthcare providers supports remote patient monitoring, making them well aligned with the growing focus on remote care and personalized healthcare solutions, which continues to drive demand for portable ECG devices.
Asia Pacific Diagnostic Electrocardiograph Market, By End User
Hospitals accounted for the largest share of the diagnostic electrocardiograph market in 2025 due to the high volume of cardiovascular patient admissions and the availability of advanced diagnostic infrastructure. The use of ECG systems with other cardiac diagnostic techniques makes their utilization more efficient in both inpatient and outpatient settings, emergency and ICUs in particular. In addition, the increasing hospital admissions due to cardiac conditions, the early detection and timely intervention have led to the hospitals being the predominant end users of ECG technologies; this trend is the major driver of overall market expansion in the diagnostic electrocardiograph market.
REGION
China to be fastest-growing country in Asia Pacific diagnostic electrocardiograph market during forecast period
China is likely to record the highest CAGR in the Asia Pacific diagnostic electrocardiograph market during the forecast period. This is mainly due to its vast and rapidly aging population and the increased incidence of cardiovascular diseases such as arrhythmias, myocardial infarctions, and hypertension. In addition, government initiatives such as Healthy China 2030, along with increased public healthcare spending, are improving access to diagnostic services and accelerating ECG adoption across hospitals and primary care settings. Furthermore, the availability of affordable, portable, and digitally connected ECG devices from domestic manufacturers is expanding cardiac screening and enabling remote monitoring in underserved regions. Collectively, these factors are positioning China as the fastest-growing market in the Asia Pacific region.
ASIA PACIFIC DIAGNOSTIC ELECTROCARDIOGRAPH MARKET: COMPANY EVALUATION MATRIX
In the Asia Pacific diagnostic electrocardiograph market matrix, GE Healthcare (Star) leads with scale, extensive distribution, and a broad solutions portfolio. NIHON KOHDEN CORPORATION (Emerging Leader) is gaining momentum with innovative diagnostic ECG devices and software. While GE Healthcare dominates through reach, Nihon’s innovation positions it for rapid growth toward the emerging leaders’ quadrant.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- GE HealthCare (US)
- Koninklijke Philips N.V. (Netherlands)
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
- NIHON KOHDEN CORPORATION (Japan)
- Baxter (US)
- FUKUDA DENSHI (Japan)
- BPL Medical Technologies (India)
- SCHILLER AG (Switzerland)
- Bionet Co., Ltd. (South Korea)
- Allengers (India)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2025 (Value) | USD 1.81 BN |
| Market Forecast in 2032 (Value) | USD 3.27 BN |
| Growth Rate | CAGR of 8.9% from 2026-2032 |
| Years Considered | 2023–2032 |
| Base Year | 2025 |
| Forecast Period | 2026–2032 |
| Units Considered | Value (USD BN), Volume (Thousand Units) |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
|
| Countries Covered | Japan, China, India, Australia, South Kora, Indonesia, Thailand, Malaysia, Rest of Asia Pacific |
WHAT IS IN IT FOR YOU: ASIA PACIFIC DIAGNOSTIC ELECTROCARDIOGRAPH MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Product Analysis | Market size estimation on diagnostic ECG software | Provided market size, key trends, growth opportunities, and a detailed competitive landscape highlighting leading providers, their product differentiators, and strategic positioning |
| Company Information | Key players: Top 3-5 players market share analysis at APAC and European country level. | Given insights on revenue shifts toward emerging device and software innovations |
| Geographic Analysis | Detailed analysis on Rest of Asia Pacific was provided to one of the top players. Client focused on ASEAN market - country-level analysis for device market. | Offered country-level demand mapping for new product launches and localization strategy planning |
RECENT DEVELOPMENTS
- October 2024 : BPL Medical Technologies inaugurated its second manufacturing facility in Bengaluru's Jigani industrial area, spanning approximately two acres. This expansion, part of India's Make in India and Atmanirbhar Bharat initiatives, aims to enhance production capabilities for various medical devices, including ECG machines. Equipped with advanced production technologies, the facility is set to meet the growing domestic demand and boost exports to global markets.
- March 2024 : Wipro GE Healthcare announced an investment of over USD 964 million over the next five years to boost local manufacturing and R&D in India. This move aims to position India as a key global MedTech innovation and manufacturing hub.
- September 2022 : Lepu Medical’s AI-ECG Tracker received China NMPA Registration Certificate for class III medical devices. Previously, AI-ECG Tracker has already obtained CE marking in 2019 and FDA approval in 2020. At the same time, AI-ECG Tracker has become the fourth AI product of Lepu that has received China NMPA Registration Certificate for class III medical devices after the AI-ECG Platform, the OmniECG B120, and the OmniECG C120.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Methodology
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.
Secondary Research
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, SEC filings of companies and publications from government sources[such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), European Federation of Pharmaceutical Industries and Associations (EFPIA), American Journal of Drug Delivery and Therapeutics, International Diabetes Federation (IDF), American Association of Diabetes Educators (AADE, Asian Association for the Study of Diabetes (AASD) and Parenteral Drug Association (PDA) were referred to identify and collect information for the Asia Pacific diagnostic electrocardiograph/ECG market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends, to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various companies and organizations in the Asia Pacific diagnostic ECG market. The primary sources from the demand side include hospitals & clinics and home care settings. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
For the market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the Asia Pacific diagnostic ECG market. All the major product manufacturers were identified at the country/regional level. Revenue mapping for the respective business segments/sub-segments was made for the major players (who contribute at least 70–75% of the market share at the global level). Also, the Asia Pacific diagnostic ECG market was split into various segments and sub-segments based on:
- List of major players operating in the Asia Pacific diagnostic ECG market at the regional and/or country level
- Product mapping of various diagnostic ECG manufacturers at the regional and/or country level
- Mapping of annual revenue generated by listed major players from Asia Pacific diagnostic ECG products (or the nearest reported business unit/product category)
- Revenue mapping of major players to cover at least 70–75% of the global market share as of 2024
- Extrapolation of the revenue mapping of the listed major players to derive the Asia Pacific diagnostic ECG market value of the respective segments/subsegments
- Summation of the market value of all segments/subsegments to arrive at the Asia Pacific diagnostic ECG market
Market Size Estimation (Bottom-up and Top-down Approach)
Data Triangulation
After arriving at the overall size of the Asia Pacific diagnostic ECG market through the methodology mentioned above, this market was split into several segments and subsegments. Where applicable, the data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.
Market Definition
Diagnostic ECG devices detect electrical signals associated with cardiac activities to produce a graphic record of the time versus voltage. These ECG devices are equipped with software that analyses the ECG graph to determine the heart rhythm. Various types of ECG devices—holter monitors, resting ECG devices, stress ECG devices, implantable loop recorders (ILRs), event monitors, mobile cardiac telemetry (MCT) devices, and smart ECG monitors—are used by healthcare professionals to monitor and diagnose cardiac conditions.
Stakeholders
- Manufacturers of diagnostic ECG devices
- Distributors of diagnostic ECG devices
- Hospitals, clinics, and cardiac centers
- Ambulatory surgery centers
- Non-government organizations
- Government regulatory authorities
- Contract manufacturers & third-party suppliers
- Research laboratories & academic institutes
- Clinical research organizations (CROs)
- Government & non-governmental regulatory authorities
- Market research & consulting firms
Report Objectives
- To define, measure, and describe the Asia Pacific diagnostic ECG market by product, lead type, type, deployment/ connectivity, end user, and region
- To provide detailed information about the significant factors influencing the Asia Pacific diagnostic ECG market growth (drivers, restraints, challenges, and opportunities)
- To strategically analyze the regulatory, pricing, value chain, supply chain, ecosystem, technology, Porter’s Five Forces, and patent analysis
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To strategically analyze the market structure, profile the key players in the Asia Pacific diagnostic ECG market, and comprehensively analyze their core competencies
- To track and analyze company developments such as acquisitions, partnerships, expansions, and product launches & approvals in the Asia Pacific diagnostic ECG market
- To track and analyze competitive developments such as mergers & acquisitions, product developments, partnerships, agreements, collaborations, and expansions in the Asia Pacific diagnostic ECG market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This ReportPersonalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Asia Pacific Diagnostic Electrocardiograph Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free Customisation
Growth opportunities and latent adjacency in Asia Pacific Diagnostic Electrocardiograph Market